n DA. Mechanisms of drug action in short-course chemotherapy. Bull Un int Tuber， 1985，60: 34. 19.Dautzenberg B. Tuberculosis: drugs resistance and therapy. Proceedings of the annual Con
gress of European Respiratory Society， Barcelona，1995. 20.Bates JH. Tuberculosis chemotherapy—The need for new antituberculosis drugs is urgent. Am J Respir Crit Care Med， 1995，151:942.
21.Geeta N. Activity of riminophenazine compounds against susceptible and drugs resistant M. tuberculosis. Tuberc Lung Dis， 1994， 75 Suppl 1:26.
22.Parak BB， Wadee AA. The synergistic effects of gamma interferon and clofazimine on phagocyte function: restoration of inhibition due to a 25 kilodalton fraction from Mycobacterium tuberculosis. Biotherapy， 1991，3:265-272.
23.Garrels JC. Clofazimine: a review of its use in leprosy and Mycobacterium avium complex infection. DICP，1991， 25:525-531.
24.Cynamon MH， Klemens SP. Activity of azithromycin against Mycobacterium avium infection in Beige mice.Antimicrob Agents Chemother， 1992，36:1611-1613.
25.Nadler JP， Berger J， Nord JA， et al. Amoxicillin-clavulanic acid for treating drug-resistant Mycobacterium tuberculosis. Chest， 1991，90:1025-1026.
26.Wong CS， Palmer GS， Cynamon MH. In vitro susceptibility of Mycobacterium tuberculosis， Mycobacterium bovis， and ticarcillin in combination with clavulanic acid. J Antimicrob Chemother， 1988， 22:863-866.
27.Parenti F. New experimental drugs for the treatment of tuberculosis. Rev infect Dis， 1989， 11 Suppl 2:S479-S483.
28.Heifets LB， Lindholm-Levy PJ， Comstock RD. Clarithromycin minimal inhibitory and bactericidal concentrations against Mycobacterium avium. Am Rev respir Dis， 1992， 145(4 Pt 1):856-858.
29.Hong Kong Chest Service/British Medical Research Council. Controlled trial of2，4， and 6 months of pyrazinamide in 6-month， three-times-weekly regimens for smear-positive pulmonary tuberculosis， including an assessment of
上一页 [1] [2] [3] [4] [5] [6] [7] [8] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文